Products/Specialty/PT-141
P
PT-141
Research Use Only
Specialty

PT-141

CAS: 189691-06-3

PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist derived from Melanotan II. It acts primarily on MC3 and MC4 receptors in the central nervous system. PT-141 is notable for being the basis of the FDA-approved drug Vyleesi for hypoactive sexual desire disorder. Unlike PDE5 inhibitors that act on the vascular system, PT-141 acts through the nervous system, representing a different mechanism of action in sexual dysfunction research.

Select Size
$49
99%+ Purity
COA Included
Same-Day Ship
US Manufactured

Technical Data

sequence
Cyclic heptapeptide
mw
1025.2 Da
purity
99.0%
form
White lyophilized powder
storage
-20°C, desiccated
solubility
Sterile water

You May Also Need